Business / Finance

RSS

IBM extends multiyear services agreement with AmerisourceBergen

IBM (NYSE: IBM) today announced that it has extended, by three years, its multiyear services agreement with AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies in the world.

1 Oct 2014

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.

30 Sep 2014

Allakos secures additional $10M investment to expand its development portfolio

Allakos Inc. announced today that it has secured an additional $10 million investment from current investors to fund development of an additional therapeutic antibody.

30 Sep 2014

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Acutus Medical, Inc. (ACM), a medical device company developing a minimally invasive real-time 3D Cardiac Chamber Imaging and Dipole Density Mapping system to identify the sources that cause and / or sustain complex cardiac arrhythmias, including atrial fibrillation, announced it has completed an additional $26.2M financing to continue developing its imaging/mapping system as well as bring to market a complete product portfolio.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

ChromaDex closes $5.0 million growth capital debt financing

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.

30 Sep 2014

Primco Management announces acquisition of 51% interest in Pops Edibles

Primco Management Inc., a medical marijuana, real estate management and multi-media company today announced that the Company has acquired a 51% interest in Pops Edibles, a San Francisco bay area based medical marijuana boutique that specializes in the formulation and manufacture of both Tetrahydrocannabinol ("THC") and Cannabidiol ("CBD") based 100% organic lollipops designed for both the medical and recreational communities.

30 Sep 2014

Baxter to establish new innovation and R&D center in Cambridge, MA

BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new lease for approximately 200,000 square feet for 12 years with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc., at 650 East Kendall Street in Cambridge, Massachusetts, which is owned by BioMed Realty through a joint venture with Prudential Real Estate Investors.

From Baxter International Inc. 30 Sep 2014

Pharmacy Value Management Solutions and Jeff Liva sign marketing deal

Advanzeon Solutions, Inc., ("Advanzeon" or the "Company"), which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), has entered into a marketing agreement (the "Agreement") with Jeff Liva & Co. ("Dr. Liva"), whereby Dr. Liva, through his Preventive PLUS division will, among other things, introduce the Company's programs to his existing and potential clients and recommend the programs for inclusion in his clients' healthcare benefit packages.

30 Sep 2014

Avanir Pharmaceuticals closes public offering of 20,930,000 shares of common stock

Avanir Pharmaceuticals, Inc. today announced the closing of its previously announced public offering of 20,930,000 shares of its common stock, including 2,730,000 shares sold pursuant to the underwriters' full exercise of their option to purchase additional shares, at a price to the public of $11.00 per share, before underwriting discounts.

29 Sep 2014

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a financing round for Oncoceutics, Inc. with additional private investors' participation.

29 Sep 2014

HerKare opens new location in Mansfield, Texas

HerKare opens a new location today in Mansfield, Texas. This marks HerKare's third center in Dallas-Fort Worth. HerKare recently expanded to Houston area and continues to accelerate their growth plans, making the treatment of hormonal imbalance in women more convenient.

29 Sep 2014

Civitis Solutions acquires Mass Adult Day Health Alliance

The Mass Adult Day Health Alliance, the largest provider of adult day health programs for elders in Massachusetts, announced today that it has been acquired by Civitis Solutions Inc., a national organization of local health and human services providers that markets its services under the name The MENTOR Network.

29 Sep 2014

Cantel Medical achieves record revenue growth in fourth quarter 2014

CANTEL MEDICAL CORP. reported net income of $10,705,000, or $0.26 per diluted share, on a 15% increase in sales to a record $131,377,000 for the fourth quarter ended July 31, 2014, inclusive of $0.02 for charges related to acquisition and CFO retirement costs.

29 Sep 2014

Tianyin Pharmaceutical's Qionglai Facility completes official GMP site visit by CFDA

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP) certification.

29 Sep 2014

Lpath closes $12.5 million registered direct offering

Lpath, Inc., the industry leader in bioactive lipid-targeted therapeutics, announced today the closing of its previously announced $12.5 million registered direct offering.

29 Sep 2014

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Dynatronics Corporation today announced results for its fiscal fourth quarter and year ended June 30, 2014.

29 Sep 2014

Daiichi Sankyo, Ambit Biosciences enter into definitive merger agreement

Daiichi Sankyo Company, Ltd. (hereinafter Daiichi Sankyo) and Ambit Biosciences, jointly announced today that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis.

29 Sep 2014

Bioniche Life Sciences announces year-end results for fiscal 2014, provides corporate update

Bioniche Life Sciences Inc. today announced financial results for its fiscal year ended June 30, 2014.

27 Sep 2014

Agrisoma Biosciences closes Series A financing round

Agrisoma Biosciences Inc. an agriculture technology company, today announced the first closing of its Series A financing round, expected to total $8 million through 2014.

27 Sep 2014